Lundbeck
HLUN-B.CO
#2625
Rank
C$8.95 B
Marketcap
C$9.44
Share price
-1.49%
Change (1 day)
11.73%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

Earnings for Lundbeck (HLUN-B.CO)

Earnings in 2025 (TTM): C$1.19 Billion

According to Lundbeck's latest financial reports the company's current earnings are C$3.61 Billion. In 2024 the company made an earning of C$0.76 Billion, an increase over its 2023 earnings that were of C$0.61 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lundbeck from 2009 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$1.19 B56.03%
2024 C$0.76 B25.74%
2023 C$0.61 B21.77%
2022 C$0.50 B31.57%
2021 C$0.38 B-4.61%
2020 C$0.39 B-45.06%
2019 C$0.72 B-34.04%
2018 C$1.10 B12.83%
2017 C$0.97 B93.99%
2016 C$0.50 B-137.28%
2015 -C$1.36 Billion-1246.24%
2014 C$0.11 B-72.36%
2013 C$0.42 B4.38%
2012 C$0.40 B-55.18%
2011 C$0.91 B5.65%
2010 C$0.86 B-5.9%
2009 C$0.91 B